NEW YORK (Reuters Health) – Tourette’s syndrome patients had a reduction in tics and other psychological symptoms during a 2-year study of bilateral thalamic deep brain stimulation, investigators…
Recruiting physicians is getting even more competitive and threatening to become a full-contact sport. That’s the key takeaway from a groundbreaking study of physician recruitment and retention trends…
NEW YORK (Reuters Health) – In postmenopausal women with osteopenia, zoledronic acid, given either once-yearly or as a single infusion, is well tolerated and effective in preventing bone…
NEW YORK (Reuters Health) – Iatrogenic preterm delivery is common among women diagnosed with invasive cancer during pregnancy, a new multicenter study shows. The study, published online in…
NEW YORK (Reuters Health) – Adding a basal or prandial insulin-based regimen to oral therapy may enhance glycemic control in patients with type 2 diabetes, according to a…
The American Medical Association and The Doctor’s Channel bring you the AMA’s Health System Reform Video Bulletin for October 22, 2009. Today we provide an update on Senate…
NEW YORK (Reuters Health) – Omega-3 fatty acid supplements do not improve the response to sertraline in heart disease patients with major depression, according to results of a…
NEW YORK (Reuters Health) – Adult survivors of childhood cancer, particularly those in poor physical health, are at increased risk for suicidal thoughts, according to an October 19…
NEW YORK (Reuters Health) – A secondary analysis of a previous study provides functional data that further supports the benefits of alteplase therapy when given up to 4.5…
NEW YORK (Reuters Health) – Patients with heart failure have fewer hospitalizations and lower mortality when they’re monitored remotely, either by routine telephone calls or electronic transfer of…
NEW YORK (Reuters Health) – Fewer than one third of patients hospitalized for heart failure are treated with aldosterone antagonists, even if they meet eligibility guidelines and are…
NEW YORK (Reuters Health) – Patients taking azathioprine or 6-mercaptopurine for inflammatory bowel disease (IBD) have more than a five-times higher risk of developing a lymphoproliferative disorder compared…
